Inhaled Prostaglandin E1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inhaled Prostaglandin E1, covering 2016-12-30 to 2016-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF) [Phase 2]